Amphastar Pharmaceuticals
AMPH
55 hedge funds and large institutions have $92.1M invested in Amphastar Pharmaceuticals in 2014 Q4 according to their latest regulatory filings, with 17 funds opening new positions, 20 increasing their positions, 10 reducing their positions, and 5 closing their positions.
240% more first-time investments, than exits
New positions opened: 17 | Existing positions closed: 5
100% more repeat investments, than reductions
Existing positions increased: 20 | Existing positions reduced: 10
22% more funds holding
Funds holding: 45 → 55 (+10)
9% more capital invested
Capital invested by funds: $84.4M → $92.1M (+$7.77M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$5.98M |
| 2 |
KCM
Kingdon Capital Management
New York
|
+$2.13M |
| 3 |
BC
Broadfin Capital
New York
|
+$1.63M |
| 4 |
FCE
Fiera Capital (Europe)
Grand Cayman,
Cayman Islands
|
+$1.32M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.16M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$4.61M |
| 2 |
DM
Deerfield Management
New York
|
-$1.51M |
| 3 |
Norges Bank
Oslo,
Norway
|
-$1.03M |
| 4 |
PAAMCP
Pacific Alternative Asset Management Company (PAAMCO)
Irvine,
California
|
-$863K |
| 5 |
BIM
Bogle Investment Management
Newton Lower Falls,
Massachusetts
|
-$614K |
AMPH Hedge Fund Activity: Q4 2014 in Review
55 of the 3,765 institutional investors tracked by Wall St. Rank reported a position in Amphastar Pharmaceuticals (AMPH) for Q4 2014, worth a combined $92.1M — up 9.2% from $84.4M a quarter earlier.
Buyers outnumbered sellers: 17 funds opened new AMPH positions and 5 closed out — a net gain of 12 holders — while 20 added to existing stakes and 10 trimmed.
The largest buyer was BlackRock Fund Advisors, adding an estimated $5.98M. The largest seller was Federated Hermes, cutting an estimated $4.61M.
- 55 institutional investors held Amphastar Pharmaceuticals (AMPH) as of Q4 2014, up from 45 in Q3 2014.
- Funds reported $92.1M of Amphastar Pharmaceuticals stock for Q4 2014, up 9.2% quarter-over-quarter.
- 17 funds opened new Amphastar Pharmaceuticals positions in Q4 2014 and 5 closed out, a net change of +12 holders.
- The largest Amphastar Pharmaceuticals buyer in Q4 2014 was BlackRock Fund Advisors, an estimated $5.98M added.
- The largest Amphastar Pharmaceuticals seller in Q4 2014 was Federated Hermes, an estimated $4.61M sold.
Based on aggregated 13F filings for Q4 2014.